Stoke Therapeutics (STOK) Prepaid Assets (2018 - 2026)

Stoke Therapeutics (STOK) recorded quarterly Prepaid Assets of $10.1 million in Q1 2026, up 130.46% quarter-over-quarter from $4.4 million in Q4 2025, and down 20.32% on a YoY basis from $12.7 million in Q1 2025.

Stoke Therapeutics (STOK) Prepaid Assets (2018 - 2026) Analysis & Trends

Stoke Therapeutics' Prepaid Assets history runs 9 years deep, the most recent figure standing at $10.1 million for Q1 2026.

  • In Q1 2026, Prepaid Assets fell 20.32% year-over-year to $10.1 million; the TTM figure through Mar 2026 stood at $10.1 million (down 20.32% YoY), while the FY2025 annual figure was $4.4 million, up 91.08% from the prior year.
  • Prepaid Assets was $10.1 million for Q1 2026 at Stoke Therapeutics, up from $4.4 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $13.2 million in Q2 2022 to a low of $2.3 million in Q4 2024.
  • Historically, Prepaid Assets has averaged $7.8 million across 5 years, with a median of $7.7 million in 2025.
  • The sharpest annual moves came in 2023 and 2025: Prepaid Assets slumped 71.93% in 2023, then soared 91.08% in 2025.
  • A 5-year view of Prepaid Assets shows it stood at $3.0 million in 2022, then fell by 13.33% to $2.6 million in 2023, then dropped by 10.31% to $2.3 million in 2024, then jumped by 91.08% to $4.4 million in 2025, then jumped by 130.46% to $10.1 million in 2026.
  • The last three Prepaid Assets figures came in at $10.1 million (Q1 2026), $4.4 million (Q4 2025), and $7.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Stoke Therapeutics 1.95 Bn 1.95 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 10.12 Mn
Dec 31, 2025 4.39 Mn
Sep 30, 2025 7.75 Mn
Jun 30, 2025 6.87 Mn
Mar 31, 2025 12.69 Mn
Dec 31, 2024 2.30 Mn
Sep 30, 2024 9.84 Mn
Jun 30, 2024 4.29 Mn
Mar 31, 2024 10.72 Mn
Dec 31, 2023 2.56 Mn
Sep 30, 2023 10.94 Mn
Jun 30, 2023 3.70 Mn
Mar 31, 2023 5.88 Mn
Dec 31, 2022 2.96 Mn
Sep 30, 2022 12.55 Mn
Jun 30, 2022 13.18 Mn
Mar 31, 2022 12.29 Mn
Dec 31, 2021 2.22 Mn
Sep 30, 2021 8.47 Mn
Jun 30, 2021 8.61 Mn